# Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Source: https://onco.cc/trials/nct06513455/  
OnCo record `nct06513455` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Harbin Medical University, not yet recruiting.

## Summary

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer is a phase 1/2, randomised interventional study registered as NCT06513455 by Harbin Medical University, with a registry enrolment figure of 132 participants, started 2024-09-01 and due to reach its primary completion in 2027-06-30. Interventions recorded: Irinotecan liposome（40mg/m2）; Nab-paclitaxel; Gemcitabine; Irinotecan Liposome（60mg/m2）. Conditions listed: Pancreatic Cancer. Primary outcome: MTD /DLT (phase I); ORR(phase II). Pancreatic eligibility wording from the registry: "Patients with pancreatic cancer diagnosed by histology or cytology;". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06513455
- Phase: 1/2
- Setting: Irinotecan Liposome Combined With Albumin Paclitaxel and Gemcitabine as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer
- Sponsor: Harbin Medical University
- Enrolled: 132

## Sources

- ClinicalTrials.gov NCT06513455: https://clinicaltrials.gov/study/NCT06513455

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06513455.json